Unlike other m6A methyltransferases, METTL14 was downregulated in HCC, and low METTL14 protein expression is associated with shorter overall survival (OS) and recurrence-free survival (17, 92, 107). The gene discussed is METTL14; the disease is hepatocellular carcinoma.